CMC Medical Center (0 mi.)
11100 Euclid Ave
Cleveland, OH 44106
Biography: Yakov Elgudin, MD, PhD
- Surgical Director, Lung Transplantation, Harrington Heart and Vascular Institute, University Hospitals
- Director, Lung Transplantation, UH Cleveland Medical Center
- Assistant Professor of Surgery, CWRU School of Medicine
- Associate Professor of Surgery, CWRU School of Medicine
Certifications & Memberships
- Thoracic and Cardiac Surgery - American Board of Thoracic Surgery
- Surgery - American Board of Surgery
Fellowship | Pediatric Cardiothoracic Surgery
Pediatric Cardiothoracic Surgery - UH Case Medical Center (2004 - 2005)
Fellowship | Cardiothoracic Surgery
Cardiothoracic Surgery - Ucla David Geffen School Of Medicine/Ucla Medical Center (2003 - 2004)
Fellowship | Cardiothoracic Surgery
Cardiothoracic Surgery - University Hospitals Of Cleveland (2002 - 2003)
Residency | General Surgery
General Surgery - Exempla St Joseph Hospital (1998 - 2002)
Internship | General Surgery
General Surgery - Exempla St Joseph Hospital (1997 - 1998)
Research Fellowship | Cardiothoracic Surgery
Cardiothoracic Surgery - Mount Sinai Morningside (1996 - 1997)
Institute Of Transplantology And Artificial Organs (1995)
Institute Of Transplantology And Artificial Organs (1991)
Kemerovo State Medical Academy (1989)
Yakov Elgudin, MD, PhD, FACS, is a cardiac surgeon and Surgical Director of Lung Transplantation with University Hospitals Harrington Heart & Vascular Institute. He is also an Associate Professor of Surgery at Case Western Reserve University School of Medicine.
Dr. Elgudin earned his medical degree from Kemerovo State Medical Institute followed by master and doctorate degrees from the Institute of Transplantation and Artificial Organs in Russia. Dr. Elgudin then completed an internship and residency in general surgery at Exempla-Saint Joseph Hospital in Denver, Colorado. He completed four fellowships – a cardiothoracic surgery fellowship at St. Luke/Roosevelt Hospital Center in New York, a cardiothoracic surgery fellowship at UCLA Medical Center, a cardiothoracic surgery fellowship at University Hospitals Cleveland Medical Center and a pediatric cardiothoracic surgery fellowship at University Hospitals Rainbow Babies & Children’s.
With his extensive training and experience, Dr. Elgudin has developed a large heart surgery practice over the years. His clinical special interests include mitral valve repair, complex aortic surgery, complex redo cardiac surgery, mechanical circulatory support, and heart and lung transplantation.
Dr. Elgudin has several patents related to bioprosthetic heart valves and is the author of more than 30 publications in national peer-reviewed journals. He is an active member of numerous prestigious organizations including the American College of Surgeons, American Heart Association, American Medical Association, International Society for Heart and Lung Transplantation, European Association for Cardiothoracic Surgery and Society of Thoracic Surgeons.
Additionally, Dr. Elgudin is President of the Russian American Medical Association and enjoys medical missions to Siberia, where he performs and teaches adult and pediatric cardiac surgery.
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Yakov Elgudin did not disclose any Outside Relationships with Industry.